Between August 4 and August 6, 2026, Eli Lilly and Company filed seventeen trademark applications covering eleven names, every one of them built on the same four letters. HIRETA, RETAHNOVA, RETAHVERA, VERAHRETA, VYMMRETA, VYMRETA, VYNNRETA and VYNRETA went in at the United States Patent and Trademark Office on August 4. YEZZRETA, YEZRETA and YEZRET followed on August 5, and the same three names were filed again at the European Union Intellectual Property Office and the UK Intellectual Property Office on August 6. Nothing has been announced under any of them.
Compiled from the public trademark register as of September 1, 2026.
Eight names in one day
All seventeen are word marks, which protect the name as plain text rather than a logo or any particular styling (types of trademarks). All seventeen sit in Nice class 5, the international category covering pharmaceutical preparations (trademark classes).
The August 4 batch is the tell. HIRETA (application 50030454), RETAHNOVA (50030457), RETAHVERA (50030461), VERAHRETA (50030464), VYMMRETA (50030465), VYMRETA (50030466), VYNNRETA (50030467) and VYNRETA (50030469) were filed on one day, through one representative, with word for word the same specification: pharmaceutical preparations, and vaccines for human use. Four of the eight are a single letter apart from each other. Two more, RETAHVERA and VERAHRETA, are the same two halves in opposite order.
The August 5 group has a different shape. YEZZRETA (50034009), YEZRETA (50034010) and YEZRET (50034013) carry a long list of treatment indications instead of the generic wording, and they are the only three Lilly took abroad: EUIPO applications 019406172, 019406122 and 019406087 on August 6, and UKIPO applications UK00004426901, UK00004426903 and UK00004427019 the same day.
What the register supports, and what it does not
The stem matches retatrutide, the triple agonist Lilly has in late-stage obesity trials. Lilly said in July that it will submit retatrutide for FDA approval in the first quarter of 2027 (CNBC, July 23, 2026), and no brand name for it has been announced. Reading this cluster as the naming shortlist for that molecule is inference, not a register fact, and it is labelled here as inference.
What the register does support is the method, which is worth more than the guess. Drug regulators reject brand names that look or sound like names already in use, so sponsors file a whole neighborhood of near-identical candidates and let examination and safety review thin it out. Filing VYMRETA, VYMMRETA, VYNRETA and VYNNRETA together is not indecision, it is a bracket. And the three names that travelled to Europe are the three Lilly paid to defend in three jurisdictions, which is the closest thing in the file to a ranking.
As of September 1 the seventeen sat at three different stages, and the difference is the interesting part. The eleven US applications were on file with no examination event on the record. The three UK applications were filed. The three EUIPO applications were published for opposition on August 14, in bulletin 2026/153. Publication opens a fixed window in which anyone who believes the mark conflicts with their own can object (opposition and cancellation). By Signa's deadline rules that window opened on August 15 and closes on November 16, 2026.
Lilly kept filing class 5 word marks after the cluster: YIELM on August 5, VUNUZE and ITEGSO on August 19, YUCEV on August 25. None of those carry the stem.
Where the register ran level with the news
August was unusual in the other direction. Most of the month's notable marks were filed at or after the announcement they belong to, not months ahead of it.
DuckLabs, Amazon Technologies, Inc. EUIPO application 019414076, a word mark in Nice classes 9 and 42, filed August 26, 2026. Amazon announced its agreement to acquire DuckLabs, the company behind the DuckDB database, that same day (GeekWire, The Register). Amazon also added a direct EU application for GRAVITON on August 7 (019406588, classes 9 and 42), a processor brand AWS has used publicly since 2018.
PICKLEJUS, NIKE Innovate C.V. Word marks in Nice class 25, filed August 25, 2026 at the UK Intellectual Property Office (UK00004435383) and the EUIPO (019413357). Nike ACG unveiled the Picklejus trail running shoe two days later, on August 27 (Nike newsroom).
LG THINQ CLAW, LG Corp. USPTO application 50051492, a word mark in classes 9, 38 and 42, filed August 14, 2026. LG unveiled ThinQ Claw, an AI agent for its connected home platform, on August 31 (LG Global Newsroom). Seventeen days of cover.
VILLAINS LAND, Disney Enterprises, Inc. USPTO application 50053270, filed August 16, 2026 in class 41. This one is a figurative mark, which protects the design as filed rather than the words on their own. Disney confirmed the land's name and its two attractions at D23 on August 15 (Disney Parks Blog), the day before the filing. Disney filed thirteen distinct marks in August, several of them parks and resorts material.
MUSE, Meta Platforms, Inc. Meta put its whole Muse line on the register in one week. MUSE CODE went in across six USPTO applications on August 5, the day Meta announced the coding agent (9to5Mac). MUSE GLIMMER followed on August 7 (50039313), three days before that model launched (CNBC). The house mark MUSE was filed at the USPTO, the EUIPO, the UKIPO and the Intellectual Property Office of Singapore, and META MUSE at the USPTO and in Singapore, between August 7 and August 9. The US, EU and Singapore applications in that group carry the one piece of register-only information in the set: a priority claim dated February 9, 2026. A priority claim back-dates an application to an earlier filing for the same mark, and February 9 is two months before Meta announced Muse Spark on April 8 (about.fb.com). The name was settled well before the first product carrying it existed in public.
Land Rush
Counting only direct national and regional filings, so that one international application is not counted once per office, August produced 29 class 42 applications matching "agent" and 10 matching "agentic". A search for "studio" in the same class and window returned 42. Class 42 covers software and technology services.
On the Watch List
- YEZZRETA, YEZRETA and YEZRET at the EUIPO. The opposition window closes November 16, 2026. Three near-identical marks published on one day is a clear target for any pharmaceutical owner holding something similar.
- The eight August 4 marks at the USPTO. First examination will show which of them survive. Near-identical siblings from one owner are rarely the obstacle; third-party marks are.
- MUSE. Under examination at the USPTO, the EUIPO and in Singapore, and filed at the UKIPO, on a February 9, 2026 priority date.
- I WOULD RATHER DIE, Amazon Technologies, Inc., EUIPO application 019410543, filed August 18 in classes 9 and 41. No public announcement matches it.
Signa reads the global register the day filings land, which is how a cluster like Lilly's shows up before anyone has written a word about it. Monitoring will flag a name in your space before the press release does.
This is reporting on the public record, not legal advice. Consult a trademark attorney for guidance specific to your situation.